Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02354508 · OUTCOME

Core Phase: Percentage of Participants With Acromegaly Shift Symptoms From Baseline to Most Extreme Post-baseline

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues · Source last updated 2019-12-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of participants
Interval / dispersion
Not reported
Time frame
Weeks 12, 24 & 36

What was measured

Symptoms of acromegaly were collected at various visits. The measurement was to be provided on a scale of 1-15 including half sizes. Investigators asked the participants to score the following symptoms of acromegaly: headache, fatigue, perspiration, paresthesias, osteoarthralgia according to a five-point score scale (0=absent, 1=mild, 2=moderate, 3=severe, 4=very severe).

Analysis population: FAS comprised all patients who had signed informed consent and had been treated with at least one dose of study medication (pasireotide LAR) after enrollment into the study

Groups in this outcome

Pasireotide LAR Overall - Acromegaly Symptom: Headache

This is the sum total of participants in under the previous treatments: lanreotide 120 mg, octreotide 30 mg or octreotide 40 mg.

Pasireotide LAR Overall - Acromegaly Symptom: Fatigue

This is the sum total of participants in under the previous treatments: lanreotide 120 mg, octreotide 30 mg or octreotide 40 mg

Pasireotide LAR Overall - Acromegaly Symptom: Perspiration

This is the sum total of participants in under the previous treatments: lanreotide 120 mg, octreotide 30 mg or octreotide 40 mg.

Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia

This is the sum total of participants in under the previous treatments: lanreotide 120 mg, octreotide 30 mg or octreotide 40 mg

Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae

This is the sum total of participants in under the previous treatments: lanreotide 120 mg, octreotide 30 mg or octreotide 40 mg

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache123
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue123
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration123
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia123
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae123

Reported measurements

Baseline (BL): Non/absent

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache51
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue45
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration53
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia41
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae67
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache41.5Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue36.6Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration43.1Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia33.3Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae54.5Not reportedNot reportedNot reportedNot reported
BL: Mild

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache31
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue23
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration31
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia26
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae31
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache25.2Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue17.8Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration25.2Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia21.1Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae25.2Not reportedNot reportedNot reportedNot reported
BL: Moderate

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache23
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue32
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration23
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia32
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae13
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache18.7Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue26.0Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration18.7Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia26.0Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae10.6Not reportedNot reportedNot reportedNot reported
BL: Severe

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache11
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue17
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration11
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia20
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae11
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache7Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue13.8Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration8.9Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia16.3Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae8.9Not reportedNot reportedNot reportedNot reported
BL: Very severe

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache7
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue6
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration5
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia4
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae1
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache5.7Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue4.9Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration4.1Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia3.3Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae0.8Not reportedNot reportedNot reportedNot reported
BL: Not done

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache0
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue0
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration0
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia0
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae0
BL: Total

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache123
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue123
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration123
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia123
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae123
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache100.0Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue100.0Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration100.0Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia100.0Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae100.0Not reportedNot reportedNot reportedNot reported
Most extr post-BL:tot Non/absent

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache45
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue32
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration46
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia33
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae58
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache36.6Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue26.0Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration37.4Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia26.8Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae47.2Not reportedNot reportedNot reportedNot reported
Most extr. post-BL: total Mild

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache38
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue28
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration36
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia32
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae34
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache30.9Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue22.8Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration29.3Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia26.0Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae27.6Not reportedNot reportedNot reportedNot reported
Most extr. post-BL: total Mod.

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache25
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue28
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration25
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia30
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae16
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache20.3Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue22.8Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration20.3Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia24.4Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae13.0Not reportedNot reportedNot reportedNot reported
Most extr. post-BL: total Severe

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache12
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue19
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration9
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia18
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae12
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache9.8Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue15.4Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration7.3Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia14.6Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae9.8Not reportedNot reportedNot reportedNot reported
Most extr post-BL:tot. Very severe

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache3
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue16
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration7
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia10
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae3
Values in Percentage of participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pasireotide LAR Overall - Acromegaly Symptom: Headache2.4Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue13.0Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration5.7Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia8.1Not reportedNot reportedNot reportedNot reported
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae2.4Not reportedNot reportedNot reportedNot reported
Most extr. post-BL: total Not done

Analysis denominator · Participants

GroupSource count
Pasireotide LAR Overall - Acromegaly Symptom: Headache0
Pasireotide LAR Overall - Acromegaly Symptom: Fatigue0
Pasireotide LAR Overall - Acromegaly Symptom: Perspiration0
Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia0
Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae0
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        41.5
      2. group Id
        OG001
        value
        36.6
      3. group Id
        OG002
        value
        43.1
      4. group Id
        OG003
        value
        33.3
      5. group Id
        OG004
        value
        54.5
    denoms
    1. counts
      1. group Id
        OG000
        value
        51
      2. group Id
        OG001
        value
        45
      3. group Id
        OG002
        value
        53
      4. group Id
        OG003
        value
        41
      5. group Id
        OG004
        value
        67
      units
      Participants
    title
    Baseline (BL): Non/absent
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        25.2
      2. group Id
        OG001
        value
        17.8
      3. group Id
        OG002
        value
        25.2
      4. group Id
        OG003
        value
        21.1
      5. group Id
        OG004
        value
        25.2
    denoms
    1. counts
      1. group Id
        OG000
        value
        31
      2. group Id
        OG001
        value
        23
      3. group Id
        OG002
        value
        31
      4. group Id
        OG003
        value
        26
      5. group Id
        OG004
        value
        31
      units
      Participants
    title
    BL: Mild
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        18.7
      2. group Id
        OG001
        value
        26.0
      3. group Id
        OG002
        value
        18.7
      4. group Id
        OG003
        value
        26.0
      5. group Id
        OG004
        value
        10.6
    denoms
    1. counts
      1. group Id
        OG000
        value
        23
      2. group Id
        OG001
        value
        32
      3. group Id
        OG002
        value
        23
      4. group Id
        OG003
        value
        32
      5. group Id
        OG004
        value
        13
      units
      Participants
    title
    BL: Moderate
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        7
      2. group Id
        OG001
        value
        13.8
      3. group Id
        OG002
        value
        8.9
      4. group Id
        OG003
        value
        16.3
      5. group Id
        OG004
        value
        8.9
    denoms
    1. counts
      1. group Id
        OG000
        value
        11
      2. group Id
        OG001
        value
        17
      3. group Id
        OG002
        value
        11
      4. group Id
        OG003
        value
        20
      5. group Id
        OG004
        value
        11
      units
      Participants
    title
    BL: Severe
  5. categories
    1. measurements
      1. group Id
        OG000
        value
        5.7
      2. group Id
        OG001
        value
        4.9
      3. group Id
        OG002
        value
        4.1
      4. group Id
        OG003
        value
        3.3
      5. group Id
        OG004
        value
        0.8
    denoms
    1. counts
      1. group Id
        OG000
        value
        7
      2. group Id
        OG001
        value
        6
      3. group Id
        OG002
        value
        5
      4. group Id
        OG003
        value
        4
      5. group Id
        OG004
        value
        1
      units
      Participants
    title
    BL: Very severe
  6. denoms
    1. counts
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        0
      3. group Id
        OG002
        value
        0
      4. group Id
        OG003
        value
        0
      5. group Id
        OG004
        value
        0
      units
      Participants
    title
    BL: Not done
  7. categories
    1. measurements
      1. group Id
        OG000
        value
        100.0
      2. group Id
        OG001
        value
        100.0
      3. group Id
        OG002
        value
        100.0
      4. group Id
        OG003
        value
        100.0
      5. group Id
        OG004
        value
        100.0
    denoms
    1. counts
      1. group Id
        OG000
        value
        123
      2. group Id
        OG001
        value
        123
      3. group Id
        OG002
        value
        123
      4. group Id
        OG003
        value
        123
      5. group Id
        OG004
        value
        123
      units
      Participants
    title
    BL: Total
  8. categories
    1. measurements
      1. group Id
        OG000
        value
        36.6
      2. group Id
        OG001
        value
        26.0
      3. group Id
        OG002
        value
        37.4
      4. group Id
        OG003
        value
        26.8
      5. group Id
        OG004
        value
        47.2
    denoms
    1. counts
      1. group Id
        OG000
        value
        45
      2. group Id
        OG001
        value
        32
      3. group Id
        OG002
        value
        46
      4. group Id
        OG003
        value
        33
      5. group Id
        OG004
        value
        58
      units
      Participants
    title
    Most extr post-BL:tot Non/absent
  9. categories
    1. measurements
      1. group Id
        OG000
        value
        30.9
      2. group Id
        OG001
        value
        22.8
      3. group Id
        OG002
        value
        29.3
      4. group Id
        OG003
        value
        26.0
      5. group Id
        OG004
        value
        27.6
    denoms
    1. counts
      1. group Id
        OG000
        value
        38
      2. group Id
        OG001
        value
        28
      3. group Id
        OG002
        value
        36
      4. group Id
        OG003
        value
        32
      5. group Id
        OG004
        value
        34
      units
      Participants
    title
    Most extr. post-BL: total Mild
  10. categories
    1. measurements
      1. group Id
        OG000
        value
        20.3
      2. group Id
        OG001
        value
        22.8
      3. group Id
        OG002
        value
        20.3
      4. group Id
        OG003
        value
        24.4
      5. group Id
        OG004
        value
        13.0
    denoms
    1. counts
      1. group Id
        OG000
        value
        25
      2. group Id
        OG001
        value
        28
      3. group Id
        OG002
        value
        25
      4. group Id
        OG003
        value
        30
      5. group Id
        OG004
        value
        16
      units
      Participants
    title
    Most extr. post-BL: total Mod.
  11. categories
    1. measurements
      1. group Id
        OG000
        value
        9.8
      2. group Id
        OG001
        value
        15.4
      3. group Id
        OG002
        value
        7.3
      4. group Id
        OG003
        value
        14.6
      5. group Id
        OG004
        value
        9.8
    denoms
    1. counts
      1. group Id
        OG000
        value
        12
      2. group Id
        OG001
        value
        19
      3. group Id
        OG002
        value
        9
      4. group Id
        OG003
        value
        18
      5. group Id
        OG004
        value
        12
      units
      Participants
    title
    Most extr. post-BL: total Severe
  12. categories
    1. measurements
      1. group Id
        OG000
        value
        2.4
      2. group Id
        OG001
        value
        13.0
      3. group Id
        OG002
        value
        5.7
      4. group Id
        OG003
        value
        8.1
      5. group Id
        OG004
        value
        2.4
    denoms
    1. counts
      1. group Id
        OG000
        value
        3
      2. group Id
        OG001
        value
        16
      3. group Id
        OG002
        value
        7
      4. group Id
        OG003
        value
        10
      5. group Id
        OG004
        value
        3
      units
      Participants
    title
    Most extr post-BL:tot. Very severe
denoms
  1. counts
    1. group Id
      OG000
      value
      123
    2. group Id
      OG001
      value
      123
    3. group Id
      OG002
      value
      123
    4. group Id
      OG003
      value
      123
    5. group Id
      OG004
      value
      123
    units
    Participants
description
Symptoms of acromegaly were collected at various visits. The measurement was to be provided on a scale of 1-15 including half sizes. Investigators asked the participants to score the following symptoms of acromegaly: headache, fatigue, perspiration, paresthesias, osteoarthralgia according to a five-point score scale (0=absent, 1=mild, 2=moderate, 3=severe, 4=very severe).
groups
  1. description
    This is the sum total of participants in under the previous treatments: lanreotide 120 mg, octreotide 30 mg or octreotide 40 mg.
    id
    OG000
    title
    Pasireotide LAR Overall - Acromegaly Symptom: Headache
  2. description
    This is the sum total of participants in under the previous treatments: lanreotide 120 mg, octreotide 30 mg or octreotide 40 mg
    id
    OG001
    title
    Pasireotide LAR Overall - Acromegaly Symptom: Fatigue
  3. description
    This is the sum total of participants in under the previous treatments: lanreotide 120 mg, octreotide 30 mg or octreotide 40 mg.
    id
    OG002
    title
    Pasireotide LAR Overall - Acromegaly Symptom: Perspiration
  4. description
    This is the sum total of participants in under the previous treatments: lanreotide 120 mg, octreotide 30 mg or octreotide 40 mg
    id
    OG003
    title
    Pasireotide LAR Overall - Acromegaly Symptom: Osteoarthralgia
  5. description
    This is the sum total of participants in under the previous treatments: lanreotide 120 mg, octreotide 30 mg or octreotide 40 mg
    id
    OG004
    title
    Pasireotide LAR Overall - Acromegaly Symptom: Paresthsiae
param Type
NUMBER
population Description
FAS comprised all patients who had signed informed consent and had been treated with at least one dose of study medication (pasireotide LAR) after enrollment into the study
reporting Status
POSTED
time Frame
Weeks 12, 24 & 36
title
Core Phase: Percentage of Participants With Acromegaly Shift Symptoms From Baseline to Most Extreme Post-baseline
type
SECONDARY
unit Of Measure
Percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice